Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom
Sponsor: Belfast Health and Social Care Trust
Summary
Short-sightedness, also called myopia, makes objects in the distance, such as the television, look blurred. This is caused by the eye growing too long, something that usually happens while children are also getting taller. People with myopia can see better with glasses or contact lenses, but this doesn't stop their eyes continuing to become more short-sighted. The CHAMP UK study is investigating a type of eye drop called atropine that might help to stop myopia getting worse as children get older.
Official title: Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children: a Multi-centre Placebo Controlled Randomised Trial in the United Kingdom
Key Details
Gender
All
Age Range
6 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
289
Start Date
2019-04-03
Completion Date
2027-02-02
Last Updated
2023-09-07
Healthy Volunteers
Yes
Conditions
Interventions
Atropine Sulfate
Atropine sulfate 0.01% eye drops which consist of 10mls of a clear colourless solution of atropine sulfate 0.01% w/v and benzalkonium chloride 0.01% w/v in sterile water.
Placebo
Placebo eye drops which consist of 10mls of a clear colourless solution of benzalkonium chloride 0.01% w/v in sterile water.
Locations (4)
Northern Ireland Clinical Research
Belfast, United Kingdom
Aston University Eye Clinic
Birmingham, United Kingdom
Anglia Ruskin University Eye Clinic
Cambridge, United Kingdom
Centre for Living (Glasgow Caledonian University)
Glasgow, United Kingdom